Back
Inter Parfums 10K Form
Sell
38
IPAR
Inter Parfums
Last Price:
119.58
Seasonality Move:
4.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-09 | 10Q | IPAR/Inter Parfums Quarterly |
2023-11-07 | 10Q | IPAR/Inter Parfums Quarterly |
2023-08-08 | 10Q | IPAR/Inter Parfums Quarterly |
2023-05-08 | 10Q | IPAR/Inter Parfums Quarterly |
2022-11-09 | 10Q | IPAR/Inter Parfums Quarterly |
2022-08-09 | 10Q | IPAR/Inter Parfums Quarterly |
Receive IPAR News And Ratings
See the #1 stock for the next 7 days that we like better than IPAR
IPAR Financial Statistics
Sales & Book Value
Annual Sales: | $1.32B |
---|---|
Cash Flow: | $34.77M |
Price / Cash Flow: | 73.32 |
Annual Sales: | $21.85 |
Price / Book: | 5.47 |
Profitability
EPS (TTM): | 4.76000 |
---|---|
Net Income (TTM): | $152.65M |
Gross Margin: | $839.08M |
Return on Equity: | 17.94% |
Return on Assets: | 11.22% |
Inter Parfums Earnings Forecast
Key Inter Parfums Financial Ratios
- The Gross Profit Margin over the past 37 years for IPAR is 63.68%.
- The Selling, General & Administrative Expenses for IPAR have been equal to 44.60% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 7.37% of Operating Income.
- The Net Earning history of IPAR is 11.59% of Total Revenues.
- Per Share Earnings over the last 37 years have been positive in 26 years.
Inter Parfums Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Personal Care Products |
Sector: | Consumer Staples |
Current Symbol: | IPAR |
CUSIP: | 458334 |
Website: | interparfumsinc.com |
Debt
Debt-to-Equity Ratio: | 0.23 |
---|---|
Current Ratio: | 2.58 |
Quick Ratio: | 1.35 |
Price-to-Earnings
Trailing P/E Ratio: | 25.17 |
---|---|
Forward P/E Ratio: | 20.73 |
IPAR Technical Analysis vs Fundamental Analysis
Sell
38
Inter Parfums (IPAR)
is a Sell
Is Inter Parfums a Buy or a Sell?
-
Inter Parfums stock is rated a Sell
The current Inter Parfums [IPAR] share price is $119.56. The Score for IPAR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.